ADITI MAS: Open Payments
NPI 1205448792 · PLANT CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,737 in 40 payments from 15 companies in 2025. Trend: 2023 $1,913 · 2024 $2,302 · 2025 $1,737
Food & beverage: $1,473Education: $263
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $476 |
| Galderma Laboratories, L.P. | 3 | $283 |
| GENZYME CORPORATION | 7 | $283 |
| Regeneron Healthcare Solutions, Inc. | 10 | $220 |
| Lilly USA, LLC | 1 | $108 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| ABBVIE INC. | 3 | $56 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 1 | $41 |
| Organon LLC | 2 | $27 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, EBGLYSS, COSENTYX, SKYRIZI, ILUMYA, Winlevi.
Industry payments across FL — which companies pay providers there.
